AusBiotech invites member contributions for the April 2025 edition of the Australasian Biotechnology journal.
We are seeking abstracts from our members on advancing Australian medtech, focusing on themes such as local manufacturing capabilities in next-generation technologies, driving sustainability in medical technology, and harnessing artificial intelligence as an enabler for medtech innovation.
In addition, we are looking for articles that offer new approaches, insights, or analyses in these areas that are welcome for inclusion in the upcoming edition.
The journal will also feature a preview of AusMedtech 2025, Australia's premier medtech conference. This flagship event will bring together local and global thought leaders to explore the latest breakthroughs, trends, and critical emerging topics across medical devices, diagnostics, and digital health, showcasing Australia's contributions to the global stage.
Australasian Biotechnology is AusBiotech's official biannual journal, published in September and April. Written by the sector, for the sector highlighting topics such as technology development, manufacturing excellence, sustainability, and strategies to strengthen Australia's end-to-end life sciences value chain.
Renowned for its informed and authoritative editorials, the journal serves as a highly effective platform to reach stakeholders across the life sciences sector. It is mailed on a name-and-title basis to more than 3,000 AusBiotech members and investors and is also available digitally.
The readership spans companies, government bodies, universities, research institutes, biotechnology organisations, and professional service providers in Australia and key international markets.
Abstracts should be 200 words and submitted to Communications team at AusBiotech by 7 February 2025.
If your abstract is accepted, the full article will be required by 19 February 2025. Articles can be approximately 500 words (1 page) or 1,000 words (2 pages). High-resolution photos to accompany articles are encouraged.
As a benefit exclusive to AusBiotech members, contributions are welcome year-round on research, business news, and sector trends; however, space in each edition is limited and inclusion is not guaranteed.
